Is Rosiglitazone as Safe as BARI 2D and the Reanalysis of RECORD Imply?

Publisher： Karger

E-ISSN： 1421-9751|127|3|152-154

ISSN： 0008-6312

Source： Cardiology, Vol.127, Iss.3, 2013-12, pp. : 152-154

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

A Reanalysis of Five Studies on Sexual Orientation and the Relative Length of the 2nd and 4th Fingers (the 2D:4D Ratio)

By McFadden Dennis Loehlin John Breedlove S. Lippa Richard Manning John Rahman Qazi

Archives of Sexual Behavior, Vol. 34, Iss. 3, 2005-06 ,pp. : 341-356

Springer Publishing Company

Access to resources Recommend Favorite

Rosiglitazone may reduce thyroid cancer risk in patients with type 2 diabetes

By Tseng Chin-Hsiao

Annals of Medicine, Vol. 45, Iss. 8, 2013-12 ,pp. : 539-544

Informa Healthcare

Access to resources Recommend Favorite

Fixed-dose combination rosiglitazone/glimepiride in the treatment of Type 2 diabetes mellitus

By Derosa Giuseppe Salvadeo Sibilla AT Cicero Arrigo FG

Therapy, Vol. 3, Iss. 5, 2006-09 ,pp. : 559-569

Future Medicine

Access to resources Recommend Favorite

Effects of rosiglitazone added to submaximal doses of metformin compared with dose escalation of metformin in type 2 diabetes: the EMPIRE Study

By Weissman P. Goldstein B. J. Rosenstock J. Waterhouse B. Cobitz A. R. Wooddell M. J. Strow L. J.

Current Medical Research and Opinion, Vol. 21, Iss. 12, 2005-12 ,pp. : 2029-2035

Informa Healthcare

Access to resources Recommend Favorite

Impact of rosiglitazone therapy on the lipid profile, glycemic control, and medication costs among type 2 diabetes patients

By Suh Dong-Churl Lee Dong-Hyun McGuire Michael Kim Chul-Min

Current Medical Research and Opinion, Vol. 27, Iss. 8, 2011-08 ,pp. : 1623-1633

Informa Healthcare

Access to resources Recommend Favorite